These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 26602236)

  • 41. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia.
    Fan SY; Wang KL; Hu W; Eisinger RS; Han A; Han CL; Wang Q; Michitomo S; Zhang JG; Wang F; Ramirez-Zamora A; Meng FG
    Ann Clin Transl Neurol; 2020 Jan; 7(1):59-68. PubMed ID: 31813194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].
    Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
    Vinke RS; Selvaraj AK; Geerlings M; Georgiev D; Sadikov A; Kubben PL; Doorduin J; Praamstra P; Bloem BR; Bartels RHMA; Esselink RAJ
    J Parkinsons Dis; 2022; 12(4):1269-1278. PubMed ID: 35367970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcomes of subthalamic nucleus deep brain stimulation for Parkinson's disease in Singapore.
    Cai YZ; Zheng Y; Li W; Saffari SE; Ng HL; Zhan A; Xu Z; Tay KY; Au WL; Ng WH; Tan LCS; Wan KR; Neo S
    Ann Acad Med Singap; 2024 Aug; 53(8):481-489. PubMed ID: 39230316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal medication profile and cost savings in Parkinson's disease patients after bilateral subthalamic nucleus deep brain stimulation.
    Ng JH; See AAQ; Xu Z; King NKK
    J Neurol; 2020 Aug; 267(8):2443-2454. PubMed ID: 32367298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimization of Microelectrode Recording in Deep Brain Stimulation Surgery Using Intraoperative Computed Tomography.
    Kochanski RB; Bus S; Pal G; Metman LV; Sani S
    World Neurosurg; 2017 Jul; 103():168-173. PubMed ID: 28408262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 3-year observation of excessive daytime sleepiness after subthalamic deep brain stimulation in patients with Parkinson's disease.
    Jung YJ; Kim HJ; Lee WW; Ehm G; Jeon B
    Clin Neurol Neurosurg; 2020 May; 192():105721. PubMed ID: 32058203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
    Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
    Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous bilateral stereotactic procedure for deep brain stimulation implants: a significant step for reducing operation time.
    Fonoff ET; Azevedo A; Angelos JS; Martinez RC; Navarro J; Reis PR; Sepulveda ME; Cury RG; Ghilardi MG; Teixeira MJ; Lopez WO
    J Neurosurg; 2016 Jul; 125(1):85-9. PubMed ID: 26684776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effects of Different Anesthesia Methods on the Treatment of Parkinson's Disease by Bilateral Deep Brain Stimulation of the Subthalamic Nucleus.
    Lu Y; Chang L; Li J; Luo B; Dong W; Qiu C; Zhang W; Ruan Y
    Front Neurosci; 2022; 16():917752. PubMed ID: 35692425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bilateral Subthalamic Nucleus Deep Brain Stimulation under General Anesthesia: Literature Review and Single Center Experience.
    Park HR; Lim YH; Song EJ; Lee JM; Park K; Park KH; Lee WW; Kim HJ; Jeon B; Paek SH
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32967337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?
    Minguez-Castellanos A; Escamilla-Sevilla F; Katati MJ; Martin-Linares JM; Meersmans M; Ortega-Moreno A; Arjona V
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):34-9. PubMed ID: 15607992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
    Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
    J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of General and Local Anesthesia for Deep Brain Stimulator Insertion: A Systematic Review.
    Sheshadri V; Rowland NC; Mehta J; Englesakis M; Manninen P; Venkatraghavan L
    Can J Neurol Sci; 2017 Nov; 44(6):697-704. PubMed ID: 28920562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial.
    Marques A; Chassin O; Morand D; Pereira B; Debilly B; Derost P; Ulla M; Lemaire JJ; Durif F
    Neurology; 2013 Aug; 81(7):633-40. PubMed ID: 23864314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.